Publications by authors named "William Hanley"

Claim this Profile
E
Exposure-safety Markov modeling of ocular adverse events in patient populations treated with tisotumab vedotin.
Summer Feng, Rudy Gunawan, Chaitali Passey, Jenna Voellinger, Daniel Polhamus, William D Hanley

J Pharmacokinet Pharmacodyn· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative Dosing Regimens of Tislelizumab Using a Pharmacometrics Model-Based Approach.
Ahsan Rizwan, Hugh Giovinazzo, Tian Yu, Yuying Gao, Kun Wang, William D Hanley

Clin Transl Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacology Overview of Tislelizumab in Patients With Advanced Tumors With a Focus on Racial Impact.
Tian Yu, Chi-Yuan Wu, Srikumar Sahasranaman, Xianbin Tian, Ying Fei Li, William D Hanley

Clin Transl Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Systems Pharmacology Model to Predict Target Occupancy by Bruton Tyrosine Kinase Inhibitors in Patients With B-Cell Malignancies.
Oleg Demin, Ying Ou, Galina Kolesova, Dmitry Shchelokov, Alexander Stepanov, William D Hanley

CPT Pharmacometrics Syst Pharmacol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacology of the Antibody-Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors.
Mei Tang, Amit Garg, Peter L Bonate, Jonathan E Rosenberg, Maria Matsangou, William D Hanley

Clin Pharmacokinet· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Family Building in Transgender Patients: Modern Strategies with Assisted Reproductive Technology Treatment.
Atoosa Ghofranian, Devora Aharon, Jenna Friedenthal, William J Hanley, Joseph A Lee

Transgend Health· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-safety and exposure-efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumors.
Chaitali Passey, Jenna Voellinger, Leonid Gibiansky, Rudy Gunawan, Leonardo Nicacio, William D Hanley

CPT Pharmacometrics Syst Pharmacol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Myomectomy With Anti-Müllerian Hormone Levels and Ovarian Reserve.
Devora Aharon, Lucky Sekhon, Chloe Getrajdman, Mackenzie Naert, William Hanley

Obstet Gynecol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic analysis for tisotumab vedotin in patients with locally advanced and/or metastatic solid tumors.
Leonid Gibiansky, Chaitali Passey, Jenna Voellinger, Rudy Gunawan, William D Hanley

CPT Pharmacometrics Syst Pharmacol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated Body Mass Index in Donor Oocyte Recipients Does Not Affect Implantation of Euploid Embryos.
Latisha E Moreta, William Hanley, Joseph A Lee, Alan B Copperman, Daniel Stein

J Womens Health (Larchmt)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Fertilization and Early Pregnancy Outcomes After Coronavirus Disease 2019 (COVID-19) Vaccination.
Devora Aharon, Matthew Lederman, Atoosa Ghofranian, Carlos Hernandez-Nieto, Chelsea Canon, William Hanley

Obstet Gynecol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of the Monoclonal Antibody MHAA4549A Administered in Combination With Oseltamivir in Patients Hospitalized With Severe Influenza A Infection.
Rong Deng, Gaohong She, Mauricio Maia, Jeremy J Lim, Melicent C Peck, William D Hanley

J Clin Pharmacol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis [corrected].
Phyllis Chan, Jiajie Yu, Leslie Chinn, Marita Prohn, Jan Huisman, William Hanley

Pharm Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis.
Phyllis Chan, Jiajie Yu, Leslie Chinn, Marita Prohn, Jan Huisman, William Hanley

Pharm Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Drug Interaction Potential Between the Hepatitis C Virus Direct-Acting Antiviral Agents Elbasvir/Grazoprevir and the Nucleotide Analog Reverse-Transcriptase Inhibitor Tenofovir Disoproxil Fumarate.
Hwa-Ping Feng, Zifang Guo, Luzelena Caro, Jennifer E Talaty, Eric Mangin, William D Hanley

Clin Pharmacol Drug Dev· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Untreated PKU Patients without Intellectual Disability: What Do They Teach Us?
Danique van Vliet, Annemiek M J van Wegberg, Kirsten Ahring, Miroslaw Bik-Multanowski, Kari Casas, William B Hanley

Nutrients· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration: Results from the Randomized Phase 2 Ladder Clinical Trial.
Peter A Campochiaro, Dennis M Marcus, Carl C Awh, Carl Regillo, Anthony P Adamis, William D Hanley

Ophthalmology· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers.
Hwa-Ping Feng, Luzelena Caro, Christine Fandozzi, Xiaoyan Chu, Zifang Guo, William D Hanley

Antimicrob Agents Chemother· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can untreated PKU patients escape from intellectual disability? A systematic review.
Danique van Vliet, Annemiek M J van Wegberg, Kirsten Ahring, Miroslaw Bik-Multanowski, Nenad Blau, William B Hanley

Orphanet J Rare Dis· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line Wild-Type Metastatic Colorectal Cancer.
Andrew G Hill, Michael P Findlay, Matthew E Burge, Christopher Jackson, Pilar Garcia Alfonso, William D Hanley

Clin Cancer Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of MHAA4549A, an Anti-Influenza A Monoclonal Antibody, in Healthy Subjects Challenged with Influenza A Virus in a Phase IIa Randomized Trial.
Rong Deng, Ai Ping Lee, Mauricio Maia, Jeremy J Lim, Tracy Burgess, William D Hanley

Clin Pharmacokinet· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Exposure-Response Analysis of RG7667, a Combination of Two Anticytomegalovirus Monoclonal Antibodies, in a Phase 2a Randomized Trial To Prevent Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.
Rong Deng, Yehong Wang, Mauricio Maia, Tracy Burgess, Jacqueline M McBride, William D Hanley

Antimicrob Agents Chemother· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB.
Robert L Avery, Alessandro A Castellarin, Nathan C Steinle, Dilsher S Dhoot, Dante J Pieramici, William D Hanley

Retina· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Utility of a Population Approach in Drug-Drug Interaction Assessments: A Simulation Evaluation.
Diane D Wang, Yanke Yu, Nastya Kassir, Min Zhu, William D Hanley

J Clin Pharmacol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment
.
K Chris Min, Kenneth C Lasseter, Thomas C Marbury, Rebecca E Wrishko, William D Hanley

Int J Clin Pharmacol Ther· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis